News & Events

  • Postdoctoral Fellow Pawan Shahi, PhD, Receives UW-Madison Stem Cell and Regenerative Medicine Center Award

    Pawan Shahi, PhD
    Pawan Shahi, PhD

    Pawan Shahi, PhD, a postdoctoral fellow in the lab of Bikash Pattnaik, PhD, received a 2018 UW-Madison Stem Cell and Regenerative Medicine Center post-doctoral award. The award provides one year of salary support for Dr. Shahi's proposal to model a compound heterozygous blindness using novel gene-editing technology.

     
  • Dr. Megan Moreno Named Associate Editor of JAMA Pediatrics

    Megan Moreno, MD, MSEd, MPH
    Megan Moreno, MD,
    MSEd, MPH

    Congratulations to Megan Moreno, MD, MSEd, MPH, who has been named an Associate Editor of JAMA Pediatrics. Dr. Moreno began her position with the February 2018 issue of the journal.

     
  • SMAHRT Research Staff Receive UW Madison Holtz Center Travel Grant

    Aubrey Gower
    Aubrey Gower
    Marina Jenkins
    Marina C. Jenkins

    Congratulations to SMAHRT research staff Aubrey Gower and Marina Jenkins, who have received a grant from the Robert E. and Jean F. Holtz Center for Science and Technology Studies to attend the 2018 annual meeting of the Society for Adolescent Health and Medicine. Aubrey and Marina, members of the Social Media and Adolescent Health Research Team lead by Dr. Megan Moreno, will be presenting their work at the March meeting in Seattle.

     
  • Dr. David Allen awarded 2018 Kaplowitz Endowed Lectureship for Quality Care

    David Allen, MD
    David Allen, MD

    Congratulations to David B. Allen, MD, who has been awarded the 2018 American Academy of Pediatrics/Pediatric Endocrine Society Kaplowitz Endowed Lectureship for Quality Care. This national award is given annually to recognize career contributions to quality and cost-effective care in Pediatric Endocrinology. Dr. Allen will present his Kaplowitz Lecture entitled “Growth-promoting treatment: Discretion is the better part of value” in May at this year’s meeting of the Pediatric Academic Societies in Toronto, Canada.

     
  • Dr. Dipesh Navsaria Receives Wisconsin Academy Fellows Award

    Posted: January 2018
    Dipesh Navsaria, MPH, MSLIS, MD
    Dipesh Navsaria, MPH,
    MSLIS, MD

    The Wisconsin Academy of Sciences, Arts & Letters today announced Dipesh Navsaria, MPH, MSLIS, MD, as one of fourteen recipients of the 2018 Academy Fellows Award, making him the first pediatrician to be named a Wisconsin Academy Fellow. Established by the Academy in 1982, the Wisconsin Academy Fellows Award recognizes educators, researchers, mentors, artists, and civic or business leaders from across Wisconsin who have made substantial contributions to the cultural life and welfare of our state and its people. The winners will be given their awards at an April 6, 2018, celebration hosted by the Wisconsin Academy at the Pyle Center at UW–Madison. The award celebration is open to the public with advance registration at wisconsinacademy.org/2018FellowsAwards.

     
  • Dr. Sharon Bartosh Named Editor-in-Chief of Pediatric Transplantation

    Posted: January 2018
    Sharon Bartosh, MD
    Sharon Bartosh, MD

    Congratulations to Sharon Bartosh, MD, a professor (CHS) and chief of the Division of Nephrology, for being named an editor-in-chief of the journal Pediatric Transplantation

    Dr. Bartosh, along with co-editor-in-chief Burkhard Tönshoff, MD, PhD, a professor of pediatrics at University Children's Hospital in Heidelberg, Germany, began her position on January 1, 2018. 

    Pediatric Transplantation is the official publication of the International Pediatric Transplant Association (IPTA), an international society of pediatric transplant health professionals across five continents and 56 countries.

    Congratulations, Dr. Bartosh, on this honor!

     
  • HuiChuan Lai, PhD, RD, and Phil Farrell, MD, PhD, Receive Grant from Cystic Fibrosis Foundation Therapeutics

    Congratulations to HuiChuan Lai, PhD, RD, Principal Investigator, and Phil Farrell, MD, PhD, Co-Principal Investigator, along with Co-Investigator Michael Rock, MD, who were recently awarded a 3-year grant from Cystic Fibrosis Foundation Therapeutics, Inc. in the amount of $1,092,063. This Clinical Research Award, entitled, "Impact of Early Malnutrition on Lung Disease Development in Cystic Fibrosis," will build on the success of her Feeding Infants Right... from the STart (FIRST) study, with expansion to 1) add chest CT and lung clearance index (LCI) assessments at 5-6 years of age and, 2) modernize biological specimen management, and 3) link the FIRST study cohort to the Cystic Fibrosis Foundation (CFF) patient registry for future, long-term outcome studies. This multi-center clinical study involves 5 CF Centers in 4 states (Utah, Wisconsin, Indiana, and Massachusetts).

     
  • HuiChuan Lai, PhD, RD, Receives NIH Supplement

    HuiChuan Lai, PhD, RD, was awarded a 1-year supplement in the amount of $153,000 from the Office of the Director and the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIDDK-NIH) to her R01 Research Grant. This Research Supplement, entitled, "Probiotic Use, Intestinal Inflammation and Gut Microbiome in Young Children with Cystic Fibrosis," has as its overall objective to determine the prevalence of probiotic supplementation and its potential benefits on reducing intestinal inflammation and modifying gut microbiome in children with Cystic Fibrosis younger than 2 years of age. Congratulations!

     
  • David McCulley, MD, Awarded ICTR Pilot Grant

    David McCulley, MD
    David McCulley, MD

    David McCulley, MD, Principal Investigator, along with Shaoqin Gong, PhD, and Naomi Chesler, PhD, UW College of Engineering, were recently awarded a $50,000 pilot grant from the UW Institute for Clinical and Translational Research (ICTR). In their one-year project, entitled "Targeted Treatment for Pulmonary Hypertension Associated with Congenital Diaphragmatic Hernia," they plan to develop and test a novel drug targeting approach utilizing the foundation of direct patient care experience and improved understanding of the genetic and molecular basis of pulmonary hypertension. The central hypothesis is that microparticle-targeted delivery of agents, such as Y-27632, to the dysfunctional pulmonary vascular smooth cells, will improve their therapeutic benefit and reduce pulmonary hypertension, while minimizing systemic side effects in infants with congenital diaphragmatic hernia (CDH). Infants with CDH often do not survive after birth due to abnormal development of the lungs and pulmonary vasculature causing lethal pulmonary hypoplasia and pulmonary hypertension.

     
  • Luke Lamers, MD, Awarded ICTR Pilot Grant

    Luke Lamers, MD
    Luke Lamers, MD

    Congratulations to Luke Lamers, MD, who was recently awarded $50,000 for his research grant entitled, "Assessment of Early vs. Delayed Catheter Intervention for Management of Pulmonary Artery Stenosis." In this one-year grant from the UW Institute for Clinical and Translational Research (ICTR), Dr. Lamers will utilize a pig model to generate detailed data regarding the common clinical problem of pulmonary artery (PA) stenosis, in order to inform better decisions about timing of surgical intervention in treatment of congenital heart disease.